Article Versions Notes

Hosui A, Tanimoto T, Okahara T, Ashida M, Ohnishi K, Wakahara Y, Kusumoto Y, Yamaguchi T, Sueyoshi Y, Hirao M, et al. Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites. Journal of Clinical Medicine. 2021; 10(2):294. https://doi.org/10.3390/jcm10020294

Hosui, Atsushi, Takafumi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, and et al. 2021. "Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites" Journal of Clinical Medicine 10, no. 2: 294. https://doi.org/10.3390/jcm10020294

Hosui, A., Tanimoto, T., Okahara, T., Ashida, M., Ohnishi, K., Wakahara, Y., Kusumoto, Y., Yamaguchi, T., Sueyoshi, Y., Hirao, M., Yamada, T., & Hiramatsu, N. (2021). Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites. Journal of Clinical Medicine, 10(2), 294. https://doi.org/10.3390/jcm10020294